New York, NY, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Basal Cell Carcinoma Treatment Market by Treatment Type (Surgery, Drugs, and Others) and by End-user (Hospitals, Specialty Clinics, and Other End Users): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024”. According to the report, global basal cell carcinoma market was valued approximately USD 5390 million in 2017 and is expected to generate revenue of around USD 9789.6 million by end of 2024, growing at a CAGR of around 8.9% between 2018 and 2024.
Basal cell carcinoma (BCC) is uncontrolled and abnormal growth is seen in the basal cells of the lower epidermis. It does not spread to other body parts but in the rare condition it may metastasize and can be proved as life-threatening; however, it may go deep in skin and bones. It is caused due to the overexposure to ultraviolet rays and the lesions formed during the BCC looks like open sores, red patches, or sometimes look like bumps. There are various treatment options available for the treatment of basal cell carcinoma which includes surgery, drugs, and others. Immunosuppressants are further expected to increase the probability of basal cell carcinoma as the immune system is compromised by the effect of these drugs.
Browse through 54 Tables & 12 Figures spread over 110 Pages and in-depth TOC on “Global Basal Cell Carcinoma Treatment Market Size 2017: Industry Type, Share, Trends and Forecast, 2024”.
Request Free Sample Report of Global Basal Cell Carcinoma Treatment Market Report @ https://www.zionmarketresearch.com/sample/basal-cell-carcinoma-treatment-market
Basal cell carcinoma market is mainly driven by the increased prevalence of various skin diseases such as melanoma and others. Furthermore, increased prevalence of cutaneous malignancies is expected to promote the growth of basal cell carcinoma treatment market. As per the American Cancer Society 2018 report, it is estimated that around 91,270 new melanoma cases will be diagnosed (about 55,150 in men and 36,120 in women). Melanoma cases are more than 20 times more common in whites as compared to African Americans. The overall lifetime risk of getting melanoma is around 0.1% (1 in 1,000) for blacks, 2.6% (1 in 38) for whites, and 0.58% (1 in 172) for Hispanics. Moreover, increase in the geriatric population, coupled with the increased prevalence of skin disorders and favorable reimbursement policies are expected to drive the growth of basal cell carcinoma treatment market.
Basal cell carcinoma market is segmented on the basis of treatment types which include surgery, drugs, and others. Surgery segment is expected to grow rapidly in the global market over the forecast period. Based on end-user, the basal cell carcinoma treatment market is segmented into hospitals, specialty clinics, and others. Hospitals segment is expected to be the fastest growing segment over the forecast period.
Download Free Report Brochure: https://www.zionmarketresearch.com/requestbrochure/basal-cell-carcinoma-treatment-market
North America is expected to contribute the major market share in basal cell carcinoma treatment market over the forecast period due to the presence of developed countries such as the U.S., Canada, Mexico, and others. Furthermore, technological advancement in healthcare infrastructure, with better and advanced healthcare facilities are further expected to propel the growth of basal cell carcinoma treatment market. The U.S. is expected to grow with the highest CAGR owing to the increased prevalence of basal cell carcinoma.
Europe is expected to the second largest region over the forecast period for basal cell carcinoma treatment market due to the presence of cold countries coupled with advanced healthcare facilities. Furthermore, increased prevalence of skin disorders is expected to drive the growth of basal cell carcinoma treatment market.
Browse the full "Basal Cell Carcinoma Treatment Market by Treatment Type (Surgery, Drugs, and Others) and by End-user (Hospitals, Specialty Clinics, and Other End Users): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024" report at https://www.zionmarketresearch.com/report/basal-cell-carcinoma-treatment-market
The Asia Pacific is the third largest region of the basal cell carcinoma treatment market and is expected to grow moderately over the forecast period. Due to the increase in geriatric population and increased prevalence of skin disorders with the increased prevalence of cancer are factors expected to promote the growth of basal cell carcinoma treatment market. Furthermore, increased awareness among people about various conditions and skin disorders are expected to support the growth of basal cell carcinoma treatment market.
Latin America and the Middle East and Africa are expected to grow at moderate growth rate over the forecast period due to the very less number of cases resulting due to the presence of a large number of African populations with high melanin pigment in their skin. All the above-mentioned factors are expected to fuel the growth of basal cell carcinoma treatment market over the forecast period.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/basal-cell-carcinoma-treatment-market
Some of the key players in basal cell carcinoma treatment market include Merck & Co. Inc., Valeant Pharmaceuticals International Inc., F. Hoffmann-La Roche Ltd., Mylan N.V., Sun Pharmaceuticals Ltd., Allergan, Inc., Allergan, Inc., Perrigo Company plc, and Strides Arcolab Ltd., amongst others.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/3297
The report segments global basal cell carcinoma treatment market as follows:
Global Basal Cell Carcinoma Treatment Market: Treatment Type Segment Analysis
- Surgical
- Drugs
- Others
Global Basal Cell Carcinoma Treatment Market: End-User Segment Analysis
- Hospitals
- Specialty Clinics
- Others
Global Basal Cell Carcinoma Treatment Market: Regional Segment Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Hepatitis B Diagnostic Tests Market: https://www.zionmarketresearch.com/report/hepatitis-b-diagnostic-tests-market
- Compounding Pharmacies Market: https://www.zionmarketresearch.com/report/compounding-pharmacies-market
- Epilepsy Therapeutics Market: https://www.zionmarketresearch.com/report/epilepsy-therapeutics-market
- Alzheimer’s Drugs Market: https://www.zionmarketresearch.com/report/alzheimers-drugs-market
- Equine Healthcare Market: https://www.zionmarketresearch.com/report/equine-healthcare-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://zmrblog.com